Seno, S.; Kimura, M.; Yashiro, Y.; Kimura, R.; Adachi, K.; Terabayashi, A.; Takahashi, M.; Oyama, T.; Abe, H.; Abe, T.;
et al. β-Thujaplicin Enhances TRAIL-Induced Apoptosis via the Dual Effects of XIAP Inhibition and Degradation in NCI-H460 Human Lung Cancer Cells. Medicines 2021, 8, 26.
https://doi.org/10.3390/medicines8060026
AMA Style
Seno S, Kimura M, Yashiro Y, Kimura R, Adachi K, Terabayashi A, Takahashi M, Oyama T, Abe H, Abe T,
et al. β-Thujaplicin Enhances TRAIL-Induced Apoptosis via the Dual Effects of XIAP Inhibition and Degradation in NCI-H460 Human Lung Cancer Cells. Medicines. 2021; 8(6):26.
https://doi.org/10.3390/medicines8060026
Chicago/Turabian Style
Seno, Saki, Minori Kimura, Yuki Yashiro, Ryutaro Kimura, Kanae Adachi, Aoi Terabayashi, Mio Takahashi, Takahiro Oyama, Hideaki Abe, Takehiko Abe,
and et al. 2021. "β-Thujaplicin Enhances TRAIL-Induced Apoptosis via the Dual Effects of XIAP Inhibition and Degradation in NCI-H460 Human Lung Cancer Cells" Medicines 8, no. 6: 26.
https://doi.org/10.3390/medicines8060026
APA Style
Seno, S., Kimura, M., Yashiro, Y., Kimura, R., Adachi, K., Terabayashi, A., Takahashi, M., Oyama, T., Abe, H., Abe, T., Tanuma, S.-i., & Takasawa, R.
(2021). β-Thujaplicin Enhances TRAIL-Induced Apoptosis via the Dual Effects of XIAP Inhibition and Degradation in NCI-H460 Human Lung Cancer Cells. Medicines, 8(6), 26.
https://doi.org/10.3390/medicines8060026
